Reich, K.; Blauvelt, A.; Thaci, D.; Leonardi, C.; Poulin, Y.; Burge, D.; Peterson, L.; Arendt, C.; Gottlieb, A. B. Maintenance of Response With Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: 48-Week Results from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). J of Skin 2017, 1, s23.